{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:56:37Z","timestamp":1774544197667,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T00:00:00Z","timestamp":1324339200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1038\/ijo.2011.232","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T13:25:40Z","timestamp":1324387540000},"page":"1062-1071","source":"Crossref","is-referenced-by-count":36,"title":["Role of mineralocorticoid receptor\/Rho\/Rho-kinase pathway in obesity-related renal injury"],"prefix":"10.1038","volume":"36","author":[{"given":"H","family":"Tokuyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Wakino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Washida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Minakuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,20]]},"reference":[{"key":"BFijo2011232_CR1","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1097\/01.ASN.0000141965.28037.EE","volume":"15","author":"SP Bagby","year":"2004","unstructured":"Bagby SP . Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease? J Am Soc Nephrol 2004; 15: 2775\u20132791.","journal-title":"J Am Soc Nephrol"},{"key":"BFijo2011232_CR2","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1681\/ASN.V1261211","volume":"12","author":"JR Henegar","year":"2001","unstructured":"Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE . Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001; 12: 1211\u20131217.","journal-title":"J Am Soc Nephrol"},{"key":"BFijo2011232_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0165-6147(00)01596-0","volume":"22","author":"Y Fukata","year":"2001","unstructured":"Fukata Y, Amano M, Kaibuchi K . Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 2001; 22: 32\u201339.","journal-title":"Trends Pharmacol Sci"},{"key":"BFijo2011232_CR4","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1046\/j.1523-1755.2003.00300.x","volume":"64","author":"T Kanda","year":"2003","unstructured":"Kanda T, Wakino S, Hayashi K, Homma K, Ozawa Y, Saruta T . Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats. Kidney Int 2003; 64: 2009\u20132019.","journal-title":"Kidney Int"},{"key":"BFijo2011232_CR5","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1124\/jpet.103.062265","volume":"309","author":"EA Wehrwein","year":"2004","unstructured":"Wehrwein EA, Northcott CA, Loberg RD, Watts SW . Rho\/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension. J Pharmacol Exp Ther 2004; 309: 1011\u20131019.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFijo2011232_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0959-437X(94)90094-9","volume":"4","author":"C Nobes","year":"1994","unstructured":"Nobes C, Hall A . Regulation and function of the Rho subfamily of small GTPases. Curr Opin Genet Dev 1994; 4: 77\u201381.","journal-title":"Curr Opin Genet Dev"},{"key":"BFijo2011232_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/oxfordjournals.jbchem.a021401","volume":"120","author":"S Narumiya","year":"1996","unstructured":"Narumiya S . The small GTPase Rho: cellular functions and signal transduction. J Biochem 1996; 120: 215\u2013228.","journal-title":"J Biochem"},{"key":"BFijo2011232_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000071888","volume":"40","author":"A Nakamura","year":"2003","unstructured":"Nakamura A, Hayashi K, Ozawa Y, Fujiwara K, Okubo K, Kanda T et al. Vessel- and vasoconstrictor-dependent role Rho\/Rho-kinase in renal microvascular tone. J Vasc Res 2003; 40: 244\u2013251.","journal-title":"J Vasc Res"},{"key":"BFijo2011232_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/01.ASN.0000039568.93355.85","volume":"13","author":"A Cavarape","year":"2003","unstructured":"Cavarape A, Endlich N, Assaloni R, Bartoli E, Steinhausen M, Parekh N et al. Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo. J Am Soc Nephrol 2003; 13: 37\u201345.","journal-title":"J Am Soc Nephrol"},{"key":"BFijo2011232_CR10","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/01.HYP.0000221605.94532.71","volume":"47","author":"Y Ishikawa","year":"2006","unstructured":"Ishikawa Y, Nishikimi T, Akimoto K, Ishimura K, Ono H, Matsuoka H . Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats. Hypertension 2006; 47: 1075\u20131083.","journal-title":"Hypertension"},{"key":"BFijo2011232_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/sj.ki.5002793","volume":"73","author":"N Sugano","year":"2008","unstructured":"Sugano N, Wakino S, Kanda T, Tatematsu S, Homma K, Yoshioka K et al. T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy. Kidney Int 2008; 73: 826\u2013834.","journal-title":"Kidney Int"},{"key":"BFijo2011232_CR12","doi-asserted-by":"publisher","first-page":"6214","DOI":"10.1074\/jbc.M110508200","volume":"277","author":"N Begum","year":"2002","unstructured":"Begum N, Sandu OA, Ito M, Lohmann SM, Smolenski A . Active Rho kinase (ROK-alpha) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J Biol Chem 2002; 277: 6214\u20136222.","journal-title":"J Biol Chem"},{"key":"BFijo2011232_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1096\/fj.05-4197fje","volume":"20","author":"T Kanda","year":"2006","unstructured":"Kanda T, Wakino S, Homma K, Yoshioka K, Tatematsu S, Hasegawa K et al. Rho-kinase as a molecular target for insulin resistance and hypertension. FASEB J 2006; 20: 169\u2013171.","journal-title":"FASEB J"},{"key":"BFijo2011232_CR14","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","volume":"63","author":"ER Blasi","year":"2003","unstructured":"Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG . Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 2003; 63: 1791\u20131800.","journal-title":"Kidney Int"},{"key":"BFijo2011232_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.HYP.0000118519.66430.22","volume":"43","author":"A Nishiyama","year":"2004","unstructured":"Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S et al. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone\/salt-induced hypertensive rats. Hypertension 2004; 43: 841\u2013848.","journal-title":"Hypertension"},{"key":"BFijo2011232_CR16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1056\/NEJM200109203451215","volume":"345","author":"A Chrysostomou","year":"2001","unstructured":"Chrysostomou A, Becker G . Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease. N Engl J Med 2001; 345: 925\u2013926.","journal-title":"N Engl J Med"},{"key":"BFijo2011232_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1161\/01.HYP.0000044937.95080.E9","volume":"41","author":"A Sato","year":"2003","unstructured":"Sato A, Hayashi K, Naruse M, Saruta T . Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension 2003; 41: 64\u201368.","journal-title":"Hypertension"},{"key":"BFijo2011232_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1464-5491.2004.01194.x","volume":"21","author":"R Rachmani","year":"2004","unstructured":"Rachmani R, Slavachevsky I, Amit M, Levi Z, Kedar Y, Berla M et al. The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study. Diabet Med 2004; 21: 471\u2013475.","journal-title":"Diabet Med"},{"key":"BFijo2011232_CR19","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.amjcard.2004.01.007","volume":"93","author":"GH Williams","year":"2004","unstructured":"Williams GH, Burgess E, Kolloch RE, Ruilope LM, Niegowska J, Kipnes MS et al. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension. Am J Cardiol 2004; 93: 990\u2013996.","journal-title":"Am J Cardiol"},{"key":"BFijo2011232_CR20","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1681\/ASN.2005121375","volume":"17","author":"GP Sun","year":"2006","unstructured":"Sun GP, Kohno M, Guo P, Nagai Y, Miyata K, Fan YY et al. Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury. J Am Soc Nephrol 2006; 17: 2193\u20132201.","journal-title":"J Am Soc Nephrol"},{"key":"BFijo2011232_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1161\/01.HYP.0000157408.43807.5a","volume":"45","author":"N Kobayashi","year":"2005","unstructured":"Kobayashi N, Hara K, Tojo A, Onozato ML, Honda T, Yoshida K et al. Eplerenone shows renoprotective effect by reducing LOX-1-mediated adhesion molecule, PKCepsilon-MAPK-p90RSK, and Rho-kinase pathway. Hypertension 2005; 45: 538\u2013544.","journal-title":"Hypertension"},{"key":"BFijo2011232_CR22","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1681\/ASN.2006080820","volume":"18","author":"H Takahashi","year":"2007","unstructured":"Takahashi H, Ichihara A, Kaneshiro Y, Inomata K, Sakoda M, Takemitsu T et al. Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade. J Am Soc Nephrol 2007; 18: 2054\u20132061.","journal-title":"J Am Soc Nephrol"},{"key":"BFijo2011232_CR23","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1681\/ASN.2004070578","volume":"16","author":"DJ Kelly","year":"2005","unstructured":"Kelly DJ, Chanty A, Gow RM, Zhang Y, Gilbert RE . Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy. J Am Soc Nephrol 2005; 16: 1654\u20131660.","journal-title":"J Am Soc Nephrol"},{"key":"BFijo2011232_CR24","doi-asserted-by":"publisher","first-page":"E1153","DOI":"10.1152\/ajpendo.00186.2007","volume":"293","author":"HR Zhou","year":"2007","unstructured":"Zhou HR, Kim EK, Kim H, Claycombe KJ . Obesity-associated mouse adipose stem cell secretion of monocyte chemotactic protein-1. Am J Physiol Endocrinol Metab 2007; 293: E1153\u2013E1158.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFijo2011232_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.chroma.2008.05.034","volume":"1200","author":"K Yamashita","year":"2008","unstructured":"Yamashita K, Okuyama M, Nakagawa R, Honma S, Satoh F, Morimoto R et al. Development of sensitive derivatization method for aldosterone in liquid chromatography-electrospray ionization tandem mass spectrometry of corticosteroids. J Chromatogr A 2008; 1200: 114\u2013121.","journal-title":"J Chromatogr A"},{"key":"BFijo2011232_CR26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/01.HYP.0000174593.88899.68","volume":"46","author":"Y Nagai","year":"2005","unstructured":"Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A et al. Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1\/2 in rat renal fibroblasts. Hypertension 2005; 46: 1039\u20131045.","journal-title":"Hypertension"},{"key":"BFijo2011232_CR27","doi-asserted-by":"publisher","first-page":"47650","DOI":"10.1074\/jbc.M108719200","volume":"276","author":"S Wakino","year":"2001","unstructured":"Wakino S, Kintscher U, Liu Z, Kim S, Yin F, Ohba M et al. Peroxisome proliferator-activated receptor gamma ligands inhibit mitogenic induction of p21(Cip1) by modulating the protein kinase Cdelta pathway in vascular smooth muscle cells. J Biol Chem 2001; 276: 47650\u201347657.","journal-title":"J Biol Chem"},{"key":"BFijo2011232_CR28","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/nm.1879","volume":"14","author":"S Shibata","year":"2008","unstructured":"Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 2008; 14: 1370\u20131376.","journal-title":"Nat Med"},{"key":"BFijo2011232_CR29","doi-asserted-by":"crossref","unstructured":"Zhou L, Yao X, Chen Y . Dexamethasone pretreatment attenuates lung and kidney injury in cholestatic rats induced by hepatic ischemia\/reperfusion. Inflammation 2011; (in press).","DOI":"10.1007\/s10753-011-9318-4"},{"key":"BFijo2011232_CR30","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1681\/ASN.2006040367","volume":"18","author":"S Tatematsu","year":"2007","unstructured":"Tatematsu S, Wakino S, Kanda T, Homma K, Yoshioka K, Hasegawa K et al. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol 2007; 18: 741\u2013749.","journal-title":"J Am Soc Nephrol"},{"key":"BFijo2011232_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/01.HYP.0000105624.68174.00","volume":"43","author":"RB de Paula","year":"2004","unstructured":"de Paula RB, da Silva AA, Hall JE . Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension 2004; 43: 41\u201347.","journal-title":"Hypertension"},{"key":"BFijo2011232_CR32","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00000441-200104000-00005","volume":"321","author":"V Thakur","year":"2001","unstructured":"Thakur V, Richards R, Reisin E . Obesity, hypertension, and the heart. Am J Med Sci 2001; 321: 242\u2013248.","journal-title":"Am J Med Sci"},{"key":"BFijo2011232_CR33","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1172\/JCI118867","volume":"98","author":"EL Greene","year":"1996","unstructured":"Greene EL, Kren S, Hostetter TH . Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 1996; 98: 1063\u20131068.","journal-title":"J Clin Invest"},{"key":"BFijo2011232_CR34","doi-asserted-by":"publisher","first-page":"E305","DOI":"10.1152\/ajpendo.00512.2007","volume":"295","author":"TY Chun","year":"2008","unstructured":"Chun TY, Chander P, Kim JW, Pratt JH, Stier CT . Aldosterone, but not angiotensin II, increased profibrotic factors in the kidney of adrenalectomized stroke prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab 2008; 295: E305\u2013E312.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFijo2011232_CR35","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/sj.ki.5000201","volume":"69","author":"J Ma","year":"2006","unstructured":"Ma J, Weisberg A, Griffin JP, Vaughan DE, Fogo AB, Brown NJ . Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury. Kidney Int 2006; 69: 1064\u20131072.","journal-title":"Kidney Int"},{"key":"BFijo2011232_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","volume":"49","author":"S Shibata","year":"2007","unstructured":"Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T . Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension 2007; 49: 355\u2013364.","journal-title":"Hypertension"},{"key":"BFijo2011232_CR37","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1097\/01.ASN.0000013702.73570.3B","volume":"13","author":"J Hou","year":"2002","unstructured":"Hou J, Speirs HJ, Seckl JR, Brown RW . Sgk1 gene expression in kidney and its regulation by aldosterone: spatio-temporal heterogeneity and quantitative analysis. J Am Soc Nephrol 2002; 13: 1190\u20131198.","journal-title":"J Am Soc Nephrol"},{"key":"BFijo2011232_CR38","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.105.539122","volume":"112","author":"M Quinkler","year":"2005","unstructured":"Quinkler M, Zehnder D, Eardley KS, Lepenies J, Howie AJ, Hughes SV et al. Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria. Circulation 2005; 112: 1435\u20131443.","journal-title":"Circulation"},{"key":"BFijo2011232_CR39","doi-asserted-by":"publisher","first-page":"R395","DOI":"10.1152\/ajpregu.00731.2004","volume":"289","author":"V Vallon","year":"2005","unstructured":"Vallon V, Huang DY, Grahammer F, Wyatt AW, Osswald H, Wulff P et al. SGK1 as a determinant of kidney function and salt intake in response to mineralocorticoid excess. Am J Physiol Regul Integr Comp Physiol 2005; 289: R395\u2013R401.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFijo2011232_CR40","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1053\/meta.2002.36311","volume":"51","author":"K Hayashi","year":"2002","unstructured":"Hayashi K, Kanda T, Homma K, Tokuyama H, Okubo K, Takamatsu I et al. Altered renal microvascular response in Zucker obese rats. Metabolism 2002; 51: 1553\u20131561.","journal-title":"Metabolism"},{"key":"BFijo2011232_CR41","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1097\/01.ASN.0000083982.74108.54","volume":"14","author":"S Arima","year":"2003","unstructured":"Arima S, Kohagura K, Xu HL, Sugawara A, Abe T, Satoh F et al. Nongenomic vascular action of aldosterone in the glomerular microcirculation. J Am Soc Nephrol 2003; 14: 2255\u20132263.","journal-title":"J Am Soc Nephrol"},{"key":"BFijo2011232_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2265.2008.03498.x","volume":"71","author":"G Lastra-Lastra","year":"2009","unstructured":"Lastra-Lastra G, Sowers JR, Restrepo-Erazo K, Manrique-Acevedo C, Lastra-Gonz\u00e1lez G . Role of aldosterone and angiotensin II in insulin resistance: an update. Clin Endocrinol (Oxf) 2009; 71: 1\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFijo2011232_CR43","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1152\/physrev.00050.2005","volume":"86","author":"F Lang","year":"2006","unstructured":"Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V . Pathophysiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev 2006; 86: 1151\u20131178.","journal-title":"Physiol Rev"},{"key":"BFijo2011232_CR44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jsbmb.2005.03.005","volume":"96","author":"T Nishikawa","year":"2005","unstructured":"Nishikawa T, Suematsu S, Saito J, Soyama A, Ito H, Kino T et al. Human renal mesangial cells produce aldosterone in response to low-density lipoprotein (LDL). J Steroid Biochem Mol Biol 2005; 96: 309\u2013316.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFijo2011232_CR45","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1096\/fj.07-9412com","volume":"22","author":"JH Jeon","year":"2008","unstructured":"Jeon JH, Kim KY, Kim JH, Baek A, Cho H, Lee YH et al. A novel adipokine CTRP1 stimulates aldosterone production. FASEB J 2008; 22: 1502\u20131511.","journal-title":"FASEB J"},{"key":"BFijo2011232_CR46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/01.ASN.0000048223.05219.E4","volume":"14","author":"CC Sharpe","year":"2003","unstructured":"Sharpe CC, Hendry BM . Signaling. Focus on Rho in renal disease. J Am Soc Nephrol 2003; 14: 261\u2013264.","journal-title":"J Am Soc Nephrol"},{"key":"BFijo2011232_CR47","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1097\/00004872-200409000-00024","volume":"22","author":"T Nishikimi","year":"2004","unstructured":"Nishikimi T, Akimoto K, Wang X, Mori Y, Tadokoro K, Ishikawa Y et al. Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats. J Hypertens 2004; 22: 1787\u20131796.","journal-title":"J Hypertens"},{"key":"BFijo2011232_CR48","first-page":"F100","volume":"293","author":"Y Ozawa","year":"2007","unstructured":"Ozawa Y, Kobori H . Crucial role of Rho-nuclear factor-kappa B axis in angiotensin II-induced renal injury. Am J Physiol 2007; 293: F100\u2013F109.","journal-title":"Am J Physiol"},{"key":"BFijo2011232_CR49","first-page":"ra3","volume":"25","author":"Y Hara","year":"2011","unstructured":"Hara Y, Wakino S, Tanabe Y, Saito M, Tokuyama H, Washida N et al. Rho and Rho-kinase activity in adipocytes contributes to a vicious cycle in obesity that may involve mechanical stretch. Sci Signal 2011; 25: ra3.","journal-title":"Sci Signal"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ijo2011232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ijo2011232","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ijo2011232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:25:59Z","timestamp":1684430759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijo2011232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,20]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["BFijo2011232"],"URL":"https:\/\/doi.org\/10.1038\/ijo.2011.232","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,20]]}}}